These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8835836)

  • 41. Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package.
    Gomeni R; Pineau G; Mentré F
    Anticancer Res; 1994; 14(6A):2321-6. PubMed ID: 7825966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Real-time adaptive sequential design for optimal acquisition of arterial spin labeling MRI data.
    Xie J; Clare S; Gallichan D; Gunn RN; Jezzard P
    Magn Reson Med; 2010 Jul; 64(1):203-10. PubMed ID: 20572144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal sampling schedule design for populations of patients.
    Tam VH; Preston SL; Drusano GL
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2888-91. PubMed ID: 12936990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stochastic differential equations in NONMEM: implementation, application, and comparison with ordinary differential equations.
    Tornøe CW; Overgaard RV; Agersø H; Nielsen HA; Madsen H; Jonsson EN
    Pharm Res; 2005 Aug; 22(8):1247-58. PubMed ID: 16078134
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Random Finite Set Based Parameter Estimation Algorithm for Identifying Stochastic Systems.
    Wang P; Li G; Peng Y; Ju R
    Entropy (Basel); 2018 Jul; 20(8):. PubMed ID: 33265657
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Robust designs in longitudinal studies accounting for parameter and model uncertainties - application to count data.
    Loingeville F; Nguyen TT; Riviere MK; Mentré F
    J Biopharm Stat; 2020; 30(1):31-45. PubMed ID: 31032703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fast clustering using adaptive density peak detection.
    Wang XF; Xu Y
    Stat Methods Med Res; 2017 Dec; 26(6):2800-2811. PubMed ID: 26475830
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administration.
    Salinger DH; Vicini P; Blough DK; O'Donnell PV; Pawlikowski MA; McCune JS
    J Clin Pharmacol; 2010 Nov; 50(11):1292-300. PubMed ID: 20075185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of methods for the estimation of carboplatin pharmacokinetics in paediatric cancer patients.
    Peng B; Boddy AV; Cole M; Pearson AD; Chatelut E; Rubie H; Newell DR
    Eur J Cancer; 1995 Oct; 31A(11):1804-10. PubMed ID: 8541105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An evaluation of population D-optimal designs via pharmacokinetic simulations.
    Hooker AC; Foracchia M; Dodds MG; Vicini P
    Ann Biomed Eng; 2003 Jan; 31(1):98-111. PubMed ID: 12572660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An improved hybrid of particle swarm optimization and the gravitational search algorithm to produce a kinetic parameter estimation of aspartate biochemical pathways.
    Ismail AM; Mohamad MS; Abdul Majid H; Abas KH; Deris S; Zaki N; Mohd Hashim SZ; Ibrahim Z; Remli MA
    Biosystems; 2017 Dec; 162():81-89. PubMed ID: 28951204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An evaluation of an optimal sampling strategy for meropenem in febrile neutropenics.
    Ariano RE; Zelenitsky SA; Nyhlén A; Sitar DS
    J Clin Pharmacol; 2005 Jul; 45(7):832-5. PubMed ID: 15951473
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Robust estimation of ultrasound pulses using outlier-resistant de-noising.
    Michailovich O; Adam D
    IEEE Trans Med Imaging; 2003 Mar; 22(3):368-81. PubMed ID: 12760554
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-constrained optimal sampling for system identification in pharmacokinetics applications with population priors and nuisance parameters.
    Sorzano COS; Pérez-De-La-Cruz Moreno MA; Burguet-Castell J; Montejo C; Ros AA
    J Pharm Sci; 2015 Jun; 104(6):2103-2109. PubMed ID: 25754898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sampling Optimization in Pharmacokinetic Bridging Studies: Example of the Use of Deferiprone in Children With β-Thalassemia.
    Bellanti F; Di Iorio VL; Danhof M; Della Pasqua O
    J Clin Pharmacol; 2016 Sep; 56(9):1094-103. PubMed ID: 26785826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimal Bayesian Adaptive Design for Test-Item Calibration.
    van der Linden WJ; Ren H
    Psychometrika; 2015 Jun; 80(2):263-88. PubMed ID: 24407735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Robustness of optimal design of fMRI experiments with application of a genetic algorithm.
    Maus B; van Breukelen GJ; Goebel R; Berger MP
    Neuroimage; 2010 Feb; 49(3):2433-43. PubMed ID: 19833212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A simultaneous d-optimal designed study for population pharmacokinetic analyses of mycophenolic Acid and tacrolimus early after renal transplantation.
    Musuamba FT; Mourad M; Haufroid V; Demeyer M; Capron A; Delattre IK; Delaruelle F; Wallemacq P; Verbeeck RK
    J Clin Pharmacol; 2012 Dec; 52(12):1833-43. PubMed ID: 22207766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An empirical multivariate log-normal distribution representing uncertainty of biokinetic parameters for 137Cs.
    Miller G; Melo D; Martz H; Bertelli L
    Radiat Prot Dosimetry; 2008; 131(2):198-211. PubMed ID: 18420573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A stochastic estimation procedure for intermittently-observed semi-Markov multistate models with back transitions.
    Aralis H; Brookmeyer R
    Stat Methods Med Res; 2019 Mar; 28(3):770-787. PubMed ID: 29117850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.